comparemela.com

Latest Breaking News On - Novartis pharma - Page 28 : comparemela.com

aurobindo pharma: Aurobindo Pharma arm signs pact with Medicines Patent Pool to develop anti-cancer drug

India s Aurobindo Pharma has announced that its subsidiary Eugia Pharma Specialities has signed a voluntary sub-licensing agreement with Medicines Patent Pool to develop and market an anti-cancer drug- Nilotinib capsules. Nilotinib capsules are used for the treatment of chronic myeloid leukemia.

Aurobindo Pharma arm signs pact with Medicines Patent Pool to develop anti-cancer drug

Aurobindo Pharma arm signs pact with Medicines Patent Pool to develop anti-cancer drug
dailyexcelsior.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailyexcelsior.com Daily Mail and Mail on Sunday newspapers.

Four manufacturers sign sub-licence agreements with MPP to produce generic versions of Nilotinib for the treatment of chronic myeloid leukaemia

Four manufacturers sign sub-licence agreements with MPP to produce generic versions of Nilotinib for the treatment of chronic myeloid leukaemia
thehindu.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindu.com Daily Mail and Mail on Sunday newspapers.

MPP inks agreement for generic version of Novartis cancer drug

MPP inks agreement for generic version of Novartis cancer drug
thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.

Medicines Patent Pool deal to make cancer drug cheaper

Medicines Patent Pool deal to make cancer drug cheaper
thehindu.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindu.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.